Roche Holding AG at American Academy of Neurology Annual Meeting Transcript
Ladies and gentlemen, welcome to the Roche Live Audio Webcast on Data Presented at AAN 2019. I'm Sherry, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Mr. Karl Mahler, Head of Investor Relations. Please go ahead, sir.
Yes. Thank you, Sherry. So good afternoon and good morning, ladies and gentlemen. I would like to extend a warm welcome to everybody joining us on the Roche audio webcast to review some of the key data which we had presented at the 2019 American Academy of Neurology, AAN, over the past week. We have about 150 participants already, so I'm very pleased to have such a high interest in this call. And in this call, we will not only review the key Roche data -- the key data presented at the congress but also give you an overview of our growing neuroscience and the rare disease franchise. This call, as you know, is a part of our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |